Osteoarthritis Was Associated With a Faster Decline in Hippocampal Volumes in Cognitively Normal Older People

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2020 Sep 14

PMID 32922280

Citations 7

Authors

Xiang Li

Qiaowen Tong

Jianqing Gao

Cailong Liu

Yangbo Liu

Affiliations

Soon will be listed here.

Abstract

Objective: To examine whether osteoarthritis (OA) is associated with a change in adjusted hippocampal volumes (HpVR: hippocampal/intracranial volume × 10) over time among cognitively normal older people.

Methods: We examined the cross-sectional and longitudinal associations of OA with HpVR among individuals with normal cognition (NC) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. At baseline, a total of 372 individuals with NC were included.

Results: In the cross-sectional analyses of baseline data, we did not find a significant relationship between OA and HpVR among individuals with NC. However, in the longitudinal analyses, OA was significantly associated with change in HpVR over time among individuals with NC. Specifically, compared with individuals without OA, those with OA showed a faster decline in HpVR over time when controlling for other potential confounders, including age, educational attainment, gender, and APOE4 genotype.

Conclusion: OA status was significantly associated with a change in HpVR over time among individuals with NC.

Citing Articles

Characterization of gene expression profiles in Alzheimer's disease and osteoarthritis: A bioinformatics study.

Liu N, Deng Q, Peng Z, Mao D, Huang Y, Meng F PLoS One. 2025; 20(2):e0316708.

PMID: 39919076 PMC: 11805404. DOI: 10.1371/journal.pone.0316708.

Brain Amyloid-β Peptide Is Associated with Pain Intensity and Cognitive Dysfunction in Osteoarthritic Patients.

Wen C, Kang H, Chan J Int J Mol Sci. 2024; 25(23.

PMID: 39684287 PMC: 11641244. DOI: 10.3390/ijms252312575.

Interconnected Pathways: Exploring Inflammation, Pain, and Cognitive Decline in Osteoarthritis.

Tarasovs M, Skuja S, Svirskis S, Sokolovska L, Vikmanis A, Lejnieks A Int J Mol Sci. 2024; 25(22).

PMID: 39595987 PMC: 11594107. DOI: 10.3390/ijms252211918.

Association of -ε4, Osteoarthritis, β-Amyloid, and Tau Accumulation in Primary Motor and Somatosensory Regions in Alzheimer Disease.

Du J, Li A, Shi D, Chen X, Wang Q, Liu Z Neurology. 2023; 101(1):e40-e49.

PMID: 37188537 PMC: 10351313. DOI: 10.1212/WNL.0000000000207369.

Association of Osteoarthritis and Functional Limitations With Cognitive Impairment Among Older Adults in the United States.

Rakutt M, Mace R, Conley C, Stone A, Duncan S, Greenberg J J Aging Health. 2023; 35(9):643-650.

PMID: 36680455 PMC: 10940858. DOI: 10.1177/08982643231153459.

References

Weber A, Mak S, Berenbaum F, Sellam J, Zheng Y, Han Y . Association between osteoarthritis and increased risk of dementia: A systemic review and meta-analysis. Medicine (Baltimore). 2019; 98(10):e14355. PMC: 6417538. DOI: 10.1097/MD.0000000000014355. View

Hunter D, Bierma-Zeinstra S . Osteoarthritis. Lancet. 2019; 393(10182):1745-1759. DOI: 10.1016/S0140-6736(19)30417-9. View

Martel-Pelletier J, Alaaeddine N, Pelletier J . Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci. 1999; 4:D694-703. DOI: 10.2741/martel. View

Huang S, Wang W, Chou L, Liao C, Liou T, Lin H . Osteoarthritis increases the risk of dementia: a nationwide cohort study in Taiwan. Sci Rep. 2015; 5:10145. PMC: 4434986. DOI: 10.1038/srep10145. View

Morales I, Guzman-Martinez L, Cerda-Troncoso C, Farias G, Maccioni R . Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci. 2014; 8:112. PMC: 4001039. DOI: 10.3389/fncel.2014.00112. View

Wang J, Wu Y, Tee B, Lo R . Medical Comorbidity in Alzheimer's Disease: A Nested Case-Control Study. J Alzheimers Dis. 2018; 63(2):773-781. DOI: 10.3233/JAD-170786. View

Westacott C, Sharif M . Cytokines in osteoarthritis: mediators or markers of joint destruction?. Semin Arthritis Rheum. 1996; 25(4):254-72. DOI: 10.1016/s0049-0172(96)80036-9. View

Chen K, Chen Y, Fan Y, Lin W, Lin W, Wang Y . Rheumatic diseases are associated with a higher risk of dementia: A nation-wide, population-based, case-control study. Int J Rheum Dis. 2017; 21(2):373-380. DOI: 10.1111/1756-185X.13246. View

Morris J . The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993; 43(11):2412-4. DOI: 10.1212/wnl.43.11.2412-a. View

10.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

11.

Liu Y, Tan L, Wang H, Liu Y, Hao X, Tan C . Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum. Mol Neurobiol. 2015; 53(7):4539-47. DOI: 10.1007/s12035-015-9388-7. View

12.

Querfurth H, LaFerla F . Alzheimer's disease. N Engl J Med. 2010; 362(4):329-44. DOI: 10.1056/NEJMra0909142. View

13.

Buchman A, Boyle P, Yu L, Shah R, Wilson R, Bennett D . Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012; 78(17):1323-9. PMC: 3335448. DOI: 10.1212/WNL.0b013e3182535d35. View

14.

Block M, Zecca L, Hong J . Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2006; 8(1):57-69. DOI: 10.1038/nrn2038. View

15.

Zhang F, Jiang L . Neuroinflammation in Alzheimer's disease. Neuropsychiatr Dis Treat. 2015; 11:243-56. PMC: 4321665. DOI: 10.2147/NDT.S75546. View

16.

Goldring M, Yamin R, Lai W . Regulation of Collagen Gene Expression by Prostaglandins and Interleukin-1beta in Cultured Chondrocytes and Fibroblasts. Am J Ther. 1996; 3(1):9-16. DOI: 10.1097/00045391-199601000-00003. View

17.

Jack Jr C, Bernstein M, Fox N, Thompson P, Alexander G, Harvey D . The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008; 27(4):685-91. PMC: 2544629. DOI: 10.1002/jmri.21049. View

18.

Heneka M, Carson M, El Khoury J, Landreth G, Brosseron F, Feinstein D . Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015; 14(4):388-405. PMC: 5909703. DOI: 10.1016/S1474-4422(15)70016-5. View

19.

Tan Z, Beiser A, Vasan R, Roubenoff R, Dinarello C, Harris T . Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology. 2007; 68(22):1902-8. DOI: 10.1212/01.wnl.0000263217.36439.da. View

20.

Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S . Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009; 73(10):768-74. PMC: 2848584. DOI: 10.1212/WNL.0b013e3181b6bb95. View